BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, February 11, 2026
Home
»
Authors
»
Rainer B. Langen
Articles by Rainer B. Langen
Schering To Purchase Collateral For $140M In Stock Exchange
March 27, 2002
By
Rainer B. Langen
Paion, Millennium Cooperate In Development Of MLN519
March 20, 2002
By
Rainer B. Langen
Co.don Starts Phase III Trials Of DISC In Herniated Discs
March 20, 2002
By
Rainer B. Langen
LION Streamlining Operations, Eliminating About 80 Positions
Feb. 20, 2002
By
Rainer B. Langen
German Officials Compromise In Embryonic Stem Cell Debate
Feb. 6, 2002
By
Rainer B. Langen
BioVisioN Raises EUR15M To Progress Programs In Peptides
Feb. 6, 2002
By
Rainer B. Langen
Biogen Paying Schering $20M Or More Over MS Drug Patents
Jan. 30, 2002
By
Rainer B. Langen
Merck KGaA Says Development Of ImClone Drug Stays On Track
Jan. 25, 2002
By
Rainer B. Langen
Estonia Expects Gene Project To Help Health, Economy; Latvia Next
Jan. 23, 2002
By
Rainer B. Langen
LION Acquiring NetGenics In Stock Deal Valued At US$17M
Jan. 23, 2002
By
Rainer B. Langen
Previous
1
2
3
4
Next
